Optain

Optain is working to make retinal screening simple, accessible, and standard in frontline care. Diabetic retinopathy is a leading cause of blindness, yet preventable and treatable with routine screening. The barrier has never been the science - it's fit. Screening tools built for specialists were never designed to fit the reality of primary care. Optain provides a complete end-to-end solution - from image capture to AI/teleophthalmology-based grading* and reporting, designed to fit within a sc[1][2]

Overview

Optain is a healthcare artificial intelligence company operating in the New York City AI scene [1]. The company works to make retinal screening simple, accessible, and standard in frontline care [2]. Diabetic retinopathy is a leading cause of blindness, yet it is preventable and treatable with routine screening [2]. According to the company, the barrier to screening has been fit rather than science, as screening tools built for specialists were not designed to fit the reality of primary care [2]. Optain provides an end-to-end solution that includes image capture, AI and teleophthalmology-based grading, and reporting, designed to fit within primary care settings [2]. The company operates in the hospitals and health care industry [3] and has 29 employees [3].

Growth & traction

LinkedIn lists 29 people working at Optain. [4]

Key people

P1 alumni

Alumni 2 went on to found or lead

Something wrong or missing? Send an update. Fixed within 24 hours.